Compile Data Set for Download or QSAR
maximum 50k data
Found 3301 with Last Name = 'venkatesan' and Initial = 'h'
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415081(CHEMBL571650)
Affinity DataKi:  5.01nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415082(CHEMBL583035)
Affinity DataKi:  5.01nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415080(CHEMBL585157)
Affinity DataKi:  6.31nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415083(CHEMBL566574)
Affinity DataKi:  6.31nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415078(CHEMBL565298)
Affinity DataKi:  10nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415084(CHEMBL565324)
Affinity DataKi:  10nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415079(CHEMBL569391)
Affinity DataKi:  10nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415077(CHEMBL584525)
Affinity DataKi:  10nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415085(CHEMBL570520)
Affinity DataKi:  12.6nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415066(CHEMBL585914)
Affinity DataKi:  15.8nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415076(CHEMBL583344)
Affinity DataKi:  25.1nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415077(CHEMBL584525)
Affinity DataKi:  100nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415085(CHEMBL570520)
Affinity DataKi:  126nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415083(CHEMBL566574)
Affinity DataKi:  158nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415082(CHEMBL583035)
Affinity DataKi:  158nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415084(CHEMBL565324)
Affinity DataKi:  158nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415076(CHEMBL583344)
Affinity DataKi:  200nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415075(CHEMBL566177)
Affinity DataKi:  200nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415080(CHEMBL585157)
Affinity DataKi:  251nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415078(CHEMBL565298)
Affinity DataKi:  251nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415075(CHEMBL566177)
Affinity DataKi:  251nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415081(CHEMBL571650)
Affinity DataKi:  316nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415079(CHEMBL569391)
Affinity DataKi:  398nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196208(1-[2-[(2,1,3-benzothiadiazol-5-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196209(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196210(1-[4-bromo-2-[(5-quinoxalinylsulfonyl)amino]benzoy...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196200(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196201(1-[2-[7-bromo(2,1,3-benzothiadiazol-4-ylsulfonyl)a...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196184(1-[3-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK2RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196202(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196185(1-[2-[(2,1,3-benzothiadiazol-4-ylcarbonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK2RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196216(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-b...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK2RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196212(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196207(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196213(1-[4-bromo-2-[5-fluoro(2,1,3-benzothiadiazol-4-yls...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196206(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196219((R)-4-[4-chloro-2-[(5-quinoxalinylsulfonyl)amino]b...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196211(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-6...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196152(1-[4-chloro-2-[(quinolin-8-ylsulfonyl)amino]-benzo...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK2RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196161(1-[4-acetylamino-2-[(2,1,3-benzothiadiazol-4-ylsul...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK2RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196215(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196214((3R,5S)-rel-4-[4-chloro-2-[(5-quinoxalinylsulfonyl...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196220(1-[4-bromo-2-[5-methyl(2,1,3-benzothiadiazol-4-yls...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196217(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196218(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196153(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196172(1-[4-bromo-2-[[naphthalen-1-ylsulfonyl]amino]benzo...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK2RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196149(4-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]be...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196150(4-[4-fluoro-2-[(5-quinoxalinylsulfonyl)amino]benzo...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196151((3S,5S)-4-[4-chloro-2-[(5-quinoxalinylsulfonyl)ami...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 3301 total ) | Next | Last >>
Jump to: